lipoxin a4 has been researched along with Cornea Injuries in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bazan, HEP; Bazan, NG; Calandria, J; Do, KV; He, J; Kakazu, AH; Lam, TF; Nshimiyimana, R; Petasis, NA; Pham, TL | 1 |
1 other study(ies) available for lipoxin a4 and Cornea Injuries
Article | Year |
---|---|
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Cellular Senescence; Corneal Injuries; COVID-19; Cytokines; Disease Models, Animal; Docosahexaenoic Acids; Drug Discovery; Epithelial Cells; Epithelium, Corneal; Humans; Lipoxins; Male; Protein Binding; Protein Domains; Rats; Rats, Sprague-Dawley; SARS-CoV-2; Signal Transduction; Spike Glycoprotein, Coronavirus; Virus Attachment; Virus Internalization | 2021 |